XTX Topco’s Allena Pharmaceuticals ALNA Stock Holding History

XTX Topco’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,443	Closed	-$19K	–	1088
2021 Q3	$19K	Buy	+21,443	New	+$21K	0.01%	643

Other funds holding ALNA

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

XTX Topco's ALNA Position: Q4 2021 in Review

XTX Topco sold out of Allena Pharmaceuticals (ALNA) in Q4 2021, closing a stake of 21,443 shares — an estimated $19K sold.

XTX Topco first reported a position in ALNA in Q3 2021 and held it in 1 quarter. The position peaked at $19K in Q3 2021. 30 funds tracked by Wall St. Rank hold ALNA as of Q4 2021.

XTX Topco reported no remaining Allena Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
XTX Topco sold 21,443 Allena Pharmaceuticals shares in Q4 2021, an estimated $19K.
XTX Topco first reported a position in Allena Pharmaceuticals in Q3 2021 and held it in 1 quarter.
XTX Topco's Allena Pharmaceuticals position peaked at $19K in Q3 2021.
30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q4 2021.

Based on XTX Topco's 13F filing for Q4 2021, filed 11 Feb 2022.